259 East Grand Avenue
South San Francisco
Freenome (free•nohm) is the dynamic collection of genetic material floating in your blood (cell-free) derived from the trillions of cells in your body. It is your living cell-free genome changing over time and space.
Founder and CEO: Gabriel Otte
Founder and COO: Riley Ennis
CTO: Michael Otte
CBO: Adam Drake
9 articles with Freenome
QIAGEN N.V. announced a partnership with Freenome, a leading artificial intelligence (AI) genomics company, to accelerate the development and commercialization of next-generation sequencing (NGS) tests to enable precision medicine in cancer treatment.
Freenome’s platform is poised to detect cancer at its earliest stages and help clinicians optimize the next generation of precision therapies.
1/8/2018Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called "liquid biopsy," in other words, blood.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
For nearly three decades, Dr. Scott has been an entrepreneur and visionary leader in genomic medicine.
Freenome announced the formation of its Scientific Advisory Board (SAB) comprised of leading experts in genomics and machine learning.